Short-chain HDAC inhibitors differentially affect vertebrate development and neuronal chromatin

ACS Medicinal Chemistry Letters

Volumn 2, Issue 1, 2011, Pages 39-42

  Fass, Daniel M ^a,c   Shah, Rishita ^b   Ghosh, Balaram ^a,c   Hennig, Krista ^a,c   Norton, Stephanie ^a,c   Zhao, Wen Ning ^a,c   Reis, Surya A ^a   Klein, Peter S ^b   Mazitschek, Ralph ^c   Maglathlin, Rebecca L ^a   Lewis, Timothy A ^a   Haggarty, Stephen J ^a,c  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

butyrate; HDAC inhibitors; histone acetylation; hydroxamic acid; phenylbutyrate; valproate

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; FOREBRAIN; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; XENOPUS LAEVIS;

ANIMALIA; VERTEBRATA; XENOPUS LAEVIS;

EID: 78651470146     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml1001954     Document Type: Article

References (25)

1. Levenson, J. M.; O'Riordan, K. J.; Brown, K. D.; Trinh, M. A.; Molfese, D. L.; Sweatt, J. D. Regulation of histone acetylation during memory formation in the hippocampus J. Biol. Chem. 2004, 279, 40545-59
2. Fischer, A.; Sananbenesi, F.; Wang, X.; Dobbin, M.; Tsai, L. H. Recovery of learning and memory is associated with chromatin remodeling Nature 2007, 447, 178-82
3. Dash, P. K.; Orsi, S. A.; Moore, A. N. Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury Neuroscience 2009, 163, 1-8
4. Stefanko, D. P.; Barrett, R. M.; Ly, A. R.; Reolon, G. K.; Wood, M. A. Modulation of long-term memory for object recognition via HDAC inhibition Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 9447-52
5. Kilgore, M.; Miller, C. A.; Fass, D. M.; Hennig, K. M.; Haggarty, S. J.; Sweatt, J. D.; Rumbaugh, G. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease Neuropsychopharmacology 2010, 35, 870-80
6. Lea, M. A.; Randolph, V. M.; Hodge, S. K. Induction of histone acetylation and growth regulation in eryrthroleukemia cells by 4-phenylbutyrate and structural analogs Anticancer Res. 1999, 19, 1971-6
7. Ricobaraza, A.; Cuadrado-Tejedor, M.; Pérez-Mediavilla, A.; Frechilla, D.; Del Río, J.; García-Osta, A. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease Neuropsychopharmacology 2009, 34, 1721-32
8. Loscher, W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy CNS Drugs 2002, 16, 669-94
9. Phiel, C. J.; Zhang, F.; Huang, E. Y.; Guenther, M. G.; Lazar, M. A.; Klein, P. S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J. Biol. Chem. 2001, 276, 36734-41
10. Gottlicher, M.; Minucci, S.; Zhu, P.; Kramer, O. H.; Schimpf, A.; Giavara, S.; Sleeman, J. P.; Lo Coco, F.; Nervi, C.; Pelicci, P. G.; Heinzel, T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells EMBO J. 2001, 20, 6969-78
11. Haddad, P. M.; Das, A.; Ashfaq, M.; Wieck, A. A review of valproate in psychiatric practice Expert Opin. Drug Metab. Toxicol. 2009, 5, 539-51
12. Walia, K. S.; Khan, E. A.; Ko, D. H.; Raza, S. S.; Khan, Y. N. Side effects of antiepileptics-a review Pain Pract. 2004, 4, 194-203
13. Gurvich, N.; Tsygankova, O. M.; Meinkoth, J. L.; Klein, P. S. Histone deacetylase is a target of valproic acid-mediated cellular differentiation Cancer Res. 2004, 64, 1079-86
14. Kavanaugh, S. A.; White, L. A.; Kolesar, J. M. Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma Am. J. Health Syst. Pharm. 2010, 67, 793-7
15. Fishbein, W. N.; Daly, J.; Streeter, C. L. Preparation and some properties of stable and carbon-14 and tritium-labeled short-chain aliphatic hydroxamic acids Anal. Biochem. 1969, 28, 13-24
16. Huang, F. C.; Shoupe, T. S.; Lin, C. J.; Lee, T. D.Y.; Chan, W. K.; Tan, J.; Schnapper, M.; Suh, J. T.; Gordon, R. J. Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis J. Med. Chem. 1989, 32, 1836-42
17. Levi, M.; Yagen, B.; Bialer, M. Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives Pharm. Res. 1997, 14, 213-7
18. Bradner, J. E.; West, N.; Grachan, M. L.; Greenberg, E. F.; Haggarty, S. J.; Warnow, T.; Mazitschek, R. Chemical phylogenetics of histone deacetylases Nat. Chem. Biol. 2010, 6, 238-43
19. Tessier, P.; Smil, D. V.; Wahhab, A.; Leit, S.; Rahil, J.; Zuomei, L.; Deziel, R.; Besterman, J. M. Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors Bioorg. Med. Chem. Lett. 2009, 19, 5684-8
20. Hubbert, C.; Guardiola, A.; Shao, R.; Kawaguchi, Y.; Ito, A.; Nixon, A.; Yoshida, M.; Wang, X. F.; Yao, T. P. HDAC6 is a microtubule-associated deacetylase Nature 2002, 417, 455-8
21. Gurvich, N.; Berman, M. G.; Wittner, B. S.; Gentleman, R. C.; Klein, P. S.; Green, J. B. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo FASEB J. 2005, 19, 1166-8
22. Eikel, D.; Hoffmann, K.; Zoll, K.; Lampen, A.; Nau, H. S -2-pentyl-4-pentynoic hydroxamic acid and its metabolite S -2-pentyl-4-pentynoic acid in the NMRI-EXENCEPHALY-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides Drug Metab. Dispos. 2006, 34, 612-20
23. Skarpidi, E.; Cao, H.; Heltweg, B.; White, B. F.; Marhenke, R. L.; Jung, M.; Stamatoyannopoulos, G. Hydroxamide derivatives of short-chain fatty acids are potent inducers of fetal globin gene expression Exp. Hematol. 2003, 31, 197-203
24. Clark, L.; Chamberlain, S. R.; Sahakian, B. J. Neurocognitive mechanisms in depression: implications for treatment Annu. Rev. Neurosci. 2009, 32, 57-74
25. Dickerson, B. C.; Eichenbaum, H. The episodic memory system: neurocircuitry and disorders Neuropsychopharmacology 2010, 35, 86-104